am 251 has been researched along with Xerostomia in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Xerostomia: Decreased salivary flow.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Prestifilippo, JP | 1 |
Medina, VA | 1 |
Mohn, CE | 1 |
Rodriguez, PA | 1 |
Elverdin, JC | 1 |
Fernandez-Solari, J | 1 |
1 other study available for am 251 and Xerostomia
Article | Year |
---|---|
Endocannabinoids mediate hyposalivation induced by inflammogens in the submandibular glands and hypothalamus.
Topics: Analysis of Variance; Animals; Cannabinoid Receptor Agonists; Dinoprostone; Endocannabinoids; Hypoth | 2013 |